<p>北達科他州投資委員會在第四季度收購了 CVS Health Corporation（紐約證券交易所代碼：CVS - 免費報告）的新頭寸，具體信息來自其最近向證券交易委員會（SEC）提交的文件。該公司收購了 43,833 股該藥房運營商的股票，價值約為 3,479,000 美元。</p>
<ul>
<li>3 只醫療保健股票將受益於這項重大法案</li>
</ul>
<p>其他一些對沖基金和機構投資者最近也增加或減少了在該公司的持股。Alteri Wealth LLC 在第三季度將其在 CVS Health 的持股增加了 3.2%。Alteri Wealth LLC 目前擁有 4,195 股該藥房運營商的股票，價值 316,000 美元，在此期間又購買了 131 股。TOWER TRUST &amp; INVESTMENT Co 在第四季度將其在 CVS Health 的持股增加了 0.8%。TOWER TRUST &amp; INVESTMENT Co 目前擁有 15,708 股該藥房運營商的股票，價值 1,247,000 美元，在此期間又購買了 132 股。Holistic Financial Partners 在第三季度將其在 CVS Health 的持股增加了 4.1%。Holistic Financial Partners 目前擁有 3,397 股該藥房運營商的股票，價值 256,000 美元，在此期間又收購了 133 股。CYBER HORNET ETFs LLC 在第三季度將其在 CVS Health 的持股增加了 4.1%。CYBER HORNET ETFs LLC 目前擁有 3,442 股該藥房運營商的股票，價值 259,000 美元，在此期間又收購了 134 股。最後，LS Investment Advisors LLC 在第四季度將其在 CVS Health 的持股增加了 3.9%。LS Investment Advisors LLC 目前擁有 3,575 股該藥房運營商的股票，價值 284,000 美元，在此期間又收購了 135 股。當前 80.66% 的股票由機構投資者和對沖基金持有。</p>
<h2>華爾街分析師觀點</h2>
<p>多位分析師對該股票發表了評論。德意志銀行將 CVS Health 的目標股價從 88.00 美元上調至 92.00 美元，並在 5 月 7 日的報告中給予該股票 “買入” 評級。高盛集團將 CVS Health 的目標股價從 95.00 美元上調至 97.00 美元，並在 2 月 12 日的研究報告中給予該股票 “買入” 評級。美國銀行將 CVS Health 的目標股價從 100.00 美元下調至 95.00 美元，並在 1 月 27 日的研究報告中為該公司設定了 “買入” 評級。Sanford C. Bernstein 將 CVS Health 的目標股價從 94.00 美元上調至 106.00 美元，並在 5 月 12 日的研究報告中給予該股票 “跑贏大盤” 評級。最後，Wall Street Zen 在 5 月 9 日的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。22 位投資分析師對該股票給予了 “買入” 評級，4 位給予了 “持有” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，平均目標股價為 98.08 美元。</p>
<ul>
<li>這隻 ETF 證明醫療保健復甦是真實的</li>
</ul>
<p><strong>查看我們關於 CVS 的最新報告</strong></p>
<h2>CVS Health 價格表現</h2>
<p>CVS 股票週一開盤價為 95.95 美元。CVS Health Corporation 的 12 個月低點為 58.50 美元，12 個月高點為 98.43 美元。該公司的市值為 1,224.2 億美元，市盈率為 42.27，市盈增長比率為 0.94，貝塔值為 0.60。該公司的速動比率為 0.66，流動比率為 0.87，債務股本比率為 0.78。該公司的 50 日移動平均線為 78.71 美元，200 日移動平均線為 78.57 美元。</p>
<ul>
<li>CVS Health 在收入增長和股息保持強勁的情況下獲利</li>
</ul>
<p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）最近在 5 月 6 日發佈了季度財報。該藥房運營商報告每股收益（EPS）為 2.57 美元，超出市場共識預期的 2.21 美元，超出幅度為 0.36 美元。CVS Health 的股本回報率為 11.88%，淨利潤率為 0.72%。該公司在本季度的收入為 1,004.3 億美元，而分析師預期為 949.9 億美元。在去年同期，該公司每股收益為 2.25 美元。CVS Health 的季度收入較去年同期增長了 6.2%。CVS Health 已將其 2026 財年的指引設定為每股收益在 7.300-7.500 之間。平均而言，股票研究分析師預測 CVS Health Corporation 在當前年度將發佈每股收益 7.44 美元。</p>
<h2>CVS Health 宣佈分紅</h2>
<p>該公司最近還披露了季度分紅，已於 5 月 4 日支付。4 月 23 日的登記投資者獲得了 0.665 美元的分紅。除息日期為 4 月 23 日。這代表着每年 2.66 美元的分紅和 2.8% 的股息收益率。CVS Health 的派息比率目前為 117.18%。</p>
<h2>內部交易活動</h2>
<p>在相關消息中，執行副總裁 Tilak Mandadi 於 5 月 8 日出售了 69,551 股公司的股票。該股票的平均售價為 89.58 美元，總價值為 6,230,378.58 美元。交易完成後，該執行副總裁直接持有公司 10,133 股，價值約為 907,714.14 美元。此次交易使其持股減少了 87.28%。該出售在向證券交易委員會提交的文件中披露，可以通過此鏈接訪問。公司內部人士持有公司股票的 0.85%。</p>
<h2>CVS Health 新聞匯總</h2>
<p>以下是本週影響 CVS Health 的主要新聞故事：</p>
<ul>
<li>積極情緒：摩根士丹利上調了對 CVS Health 的目標股價，並維持了增持評級，表明對公司超出預期的季度業績後進一步上漲的信心。摩根士丹利對 CVS Health 發佈積極預測 NYSE: CVS 股價</li>
<li>積極情緒：Argus 也提升了對 CVS Health 的展望，進一步增加了分析師支持的浪潮，這可能幫助股價上漲。Argus 對 CVS Health 發佈積極預測 NYSE: CVS 股價</li>
<li>積極情緒：CVS 最近公佈了 2026 年第一季度的強勁業績，收入和調整後每股收益均超出預期，這繼續推動投資者對執行和估值的樂觀情緒。以下是為什麼 CVS Health (CVS) 是未來 10 年值得購買的便宜股票</li>
<li>積極情緒：CVS 與 WGU 推出了一項在線藥學預科學位項目，以幫助建立更強大的藥劑師人才管道，這一舉措可能支持長期的人力資源和服務增長。CVS Health®與 WGU 推出全國未來藥劑師的在線藥學預科項目</li>
<li>中性情緒：CVS 通過在破產法庭批准後出售 Omnicare，推進了其投資組合重組，這簡化了業務並剔除了一個表現不佳的單位，但也確認了持續的重組。CVS 通過 Omnicare 出售和無人機推廣重新聚焦核心健康平台</li>
<li>中性情緒：CVS 還強調了在羅德島的社區和品牌建設舉措，包括其經濟影響報告和擴大 WIC 接受度，這對聲譽是積極的，但不太可能單獨推動股價。CVS Health 在羅德島的年度影響</li>
</ul>
<h2>關於 CVS Health</h2>
<p>（免費報告）</p>
<p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療解決方案。公司總部位於羅德島的伍恩索克特，追溯到 20 世紀 60 年代初，已發展成為一個綜合的處方藥、非處方產品、臨牀服務和健康保險提供商。其運營模式結合了零售藥房位置和店內診所，以及更廣泛的藥房和健康計劃能力。</p>
<p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 步入式醫療診所和提供擴展臨牀服務的 HealthHUB 地點。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票超過 CVS Health</li>
<li>Robinhood、SoFi 和 Webull 講述截然不同的故事</li>
<li>當博通市值超過 2 萬億美元時，私人信貸巨頭想要參與</li>
<li>通過這些 ETF 瞄準火熱的分拆和合並領域</li>
<li>隨着 AI 內存需求激增，三星加入 1 萬億美元俱樂部</li>
</ul>
<p><strong>想看看其他對 CVS 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com，獲取 CVS Health Corporation (NYSE:CVS - 免費報告) 的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 CVS Health 嗎？</h2>
<p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄推薦給客户的股票，以便在更廣泛的市場注意到之前購買……而 CVS Health 並不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

最新一批13F持倉出爐：波克夏Q1加倉谷歌A類超200%，躍升至第七大重倉股；徹底清倉持有近七年的亞馬遜以及Visa、萬事達、聯合健康，並時隔六年重新殺回航空股，斥資26.5億美元建倉達美航空。橋水則首次建倉台積電與黃金ETF（GLD），加倉亞馬遜（升至第一大重倉股）、英偉達、博通、美光；同時清倉賽富時、ServiceNow，減持萬事達、Adobe等。機構資金正集中流向AI算力與避險資產。你的持倉裡，有幾隻被巨頭點名？

<p>最新一批13F持倉出爐：波克夏Q1加倉谷歌A類超200%，躍升至第七大重倉股；徹底清倉持有近七年的亞馬遜以及Visa、萬事達、聯合健康，並時隔六年重新殺回航空股，斥資26.5億美元建倉達美航空。橋水則首次建倉台積電與黃金ETF（GLD），加倉亞馬遜（升至第一大重倉股）、英偉達、博通、美光；同時清倉賽富時、ServiceNow，減持萬事達、Adobe等。機構資金正集中流向AI算力與避險資產。你的持倉裡，有幾隻被巨頭點名？</p>

巨頭13F出爐：押注AI算力與避險

西維斯

<p>根據 SEC 的文件，北達科他州投資委員會在第四季度收購了 43,833 股 CVS Health Corporation（紐約證券交易所代碼：CVS），價值約 348 萬美元。其他機構投資者也調整了他們在 CVS 的持股。分析師對 CVS 給予了 “適度買入” 的評級，目標價格範圍在 92 美元到 106 美元之間。CVS 報告第一季度每股收益為 2.57 美元，超出預期，收入為 1004.3 億美元，同比增長 6.2%</p>

<p>North Dakota State Investment Board acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 43,833 shares of the pharmacy operator's stock, valued at approximately $3,479,000.</p>
<div class="lb-trans"><p>北達科他州投資委員會在第四季度收購了 CVS Health Corporation（紐約證券交易所代碼：CVS - 免費報告）的新頭寸，具體信息來自其最近向證券交易委員會（SEC）提交的文件。該公司收購了 43,833 股該藥房運營商的股票，價值約為 3,479,000 美元。</p>
</div><ul>
<li>3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只醫療保健股票將受益於這項重大法案</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Alteri Wealth LLC increased its position in CVS Health by 3.2% in the third quarter. Alteri Wealth LLC now owns 4,195 shares of the pharmacy operator's stock worth $316,000 after purchasing an additional 131 shares during the period. TOWER TRUST &amp; INVESTMENT Co increased its position in CVS Health by 0.8% in the fourth quarter. TOWER TRUST &amp; INVESTMENT Co now owns 15,708 shares of the pharmacy operator's stock worth $1,247,000 after purchasing an additional 132 shares during the period. Holistic Financial Partners grew its holdings in CVS Health by 4.1% during the 3rd quarter. Holistic Financial Partners now owns 3,397 shares of the pharmacy operator's stock worth $256,000 after acquiring an additional 133 shares during the period. CYBER HORNET ETFs LLC grew its holdings in CVS Health by 4.1% during the 3rd quarter. CYBER HORNET ETFs LLC now owns 3,442 shares of the pharmacy operator's stock worth $259,000 after acquiring an additional 134 shares during the period. Finally, LS Investment Advisors LLC grew its holdings in CVS Health by 3.9% during the 4th quarter. LS Investment Advisors LLC now owns 3,575 shares of the pharmacy operator's stock worth $284,000 after acquiring an additional 135 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些對沖基金和機構投資者最近也增加或減少了在該公司的持股。Alteri Wealth LLC 在第三季度將其在 CVS Health 的持股增加了 3.2%。Alteri Wealth LLC 目前擁有 4,195 股該藥房運營商的股票，價值 316,000 美元，在此期間又購買了 131 股。TOWER TRUST &amp; INVESTMENT Co 在第四季度將其在 CVS Health 的持股增加了 0.8%。TOWER TRUST &amp; INVESTMENT Co 目前擁有 15,708 股該藥房運營商的股票，價值 1,247,000 美元，在此期間又購買了 132 股。Holistic Financial Partners 在第三季度將其在 CVS Health 的持股增加了 4.1%。Holistic Financial Partners 目前擁有 3,397 股該藥房運營商的股票，價值 256,000 美元，在此期間又收購了 133 股。CYBER HORNET ETFs LLC 在第三季度將其在 CVS Health 的持股增加了 4.1%。CYBER HORNET ETFs LLC 目前擁有 3,442 股該藥房運營商的股票，價值 259,000 美元，在此期間又收購了 134 股。最後，LS Investment Advisors LLC 在第四季度將其在 CVS Health 的持股增加了 3.9%。LS Investment Advisors LLC 目前擁有 3,575 股該藥房運營商的股票，價值 284,000 美元，在此期間又收購了 135 股。當前 80.66% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>A number of analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on shares of CVS Health from $88.00 to $92.00 and gave the stock a &#34;buy&#34; rating in a report on Thursday, May 7th. The Goldman Sachs Group boosted their target price on CVS Health from $95.00 to $97.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, February 12th. Bank of America decreased their target price on CVS Health from $100.00 to $95.00 and set a &#34;buy&#34; rating for the company in a research report on Tuesday, January 27th. Sanford C. Bernstein boosted their target price on CVS Health from $94.00 to $106.00 and gave the stock an &#34;outperform&#34; rating in a research report on Tuesday, May 12th. Finally, Wall Street Zen upgraded CVS Health from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, May 9th. Twenty-two investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of &#34;Moderate Buy&#34; and an average target price of $98.08.</p>
<div class="lb-trans"><p>多位分析師對該股票發表了評論。德意志銀行將 CVS Health 的目標股價從 88.00 美元上調至 92.00 美元，並在 5 月 7 日的報告中給予該股票 “買入” 評級。高盛集團將 CVS Health 的目標股價從 95.00 美元上調至 97.00 美元，並在 2 月 12 日的研究報告中給予該股票 “買入” 評級。美國銀行將 CVS Health 的目標股價從 100.00 美元下調至 95.00 美元，並在 1 月 27 日的研究報告中為該公司設定了 “買入” 評級。Sanford C. Bernstein 將 CVS Health 的目標股價從 94.00 美元上調至 106.00 美元，並在 5 月 12 日的研究報告中給予該股票 “跑贏大盤” 評級。最後，Wall Street Zen 在 5 月 9 日的研究報告中將 CVS Health 的評級從 “持有” 上調至 “買入”。22 位投資分析師對該股票給予了 “買入” 評級，4 位給予了 “持有” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “適度買入”，平均目標股價為 98.08 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>這隻 ETF 證明醫療保健復甦是真實的</li>
</ul>
</div><p><strong>Check Out Our Latest Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 CVS 的最新報告</strong></p>
</div><h2>CVS Health Price Performance</h2>
<div class="lb-trans"><h2>CVS Health 價格表現</h2>
</div><p>Shares of CVS stock opened at $95.95 on Monday. CVS Health Corporation has a 12-month low of $58.50 and a 12-month high of $98.43. The firm has a market capitalization of $122.42 billion, a price-to-earnings ratio of 42.27, a price-to-earnings-growth ratio of 0.94 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The firm has a fifty day moving average of $78.71 and a 200-day moving average of $78.57.</p>
<div class="lb-trans"><p>CVS 股票週一開盤價為 95.95 美元。CVS Health Corporation 的 12 個月低點為 58.50 美元，12 個月高點為 98.43 美元。該公司的市值為 1,224.2 億美元，市盈率為 42.27，市盈增長比率為 0.94，貝塔值為 0.60。該公司的速動比率為 0.66，流動比率為 0.87，債務股本比率為 0.78。該公司的 50 日移動平均線為 78.71 美元，200 日移動平均線為 78.57 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 在收入增長和股息保持強勁的情況下獲利</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. During the same period in the previous year, the firm earned $2.25 EPS. CVS Health's quarterly revenue was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities research analysts forecast that CVS Health Corporation will post 7.44 earnings per share for the current year.</p>
<div class="lb-trans"><p>CVS Health（紐約證券交易所代碼：CVS - 獲取免費報告）最近在 5 月 6 日發佈了季度財報。該藥房運營商報告每股收益（EPS）為 2.57 美元，超出市場共識預期的 2.21 美元，超出幅度為 0.36 美元。CVS Health 的股本回報率為 11.88%，淨利潤率為 0.72%。該公司在本季度的收入為 1,004.3 億美元，而分析師預期為 949.9 億美元。在去年同期，該公司每股收益為 2.25 美元。CVS Health 的季度收入較去年同期增長了 6.2%。CVS Health 已將其 2026 財年的指引設定為每股收益在 7.300-7.500 之間。平均而言，股票研究分析師預測 CVS Health Corporation 在當前年度將發佈每股收益 7.44 美元。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣佈分紅</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. CVS Health's payout ratio is currently 117.18%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度分紅，已於 5 月 4 日支付。4 月 23 日的登記投資者獲得了 0.665 美元的分紅。除息日期為 4 月 23 日。這代表着每年 2.66 美元的分紅和 2.8% 的股息收益率。CVS Health 的派息比率目前為 117.18%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部交易活動</h2>
</div><p>In related news, EVP Tilak Mandadi sold 69,551 shares of the business's stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. The trade was a 87.28% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.85% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，執行副總裁 Tilak Mandadi 於 5 月 8 日出售了 69,551 股公司的股票。該股票的平均售價為 89.58 美元，總價值為 6,230,378.58 美元。交易完成後，該執行副總裁直接持有公司 10,133 股，價值約為 907,714.14 美元。此次交易使其持股減少了 87.28%。該出售在向證券交易委員會提交的文件中披露，可以通過此鏈接訪問。公司內部人士持有公司股票的 0.85%。</p>
</div><h2>CVS Health News Roundup</h2>
<div class="lb-trans"><h2>CVS Health 新聞匯總</h2>
</div><p>Here are the key news stories impacting CVS Health this week:</p>
<div class="lb-trans"><p>以下是本週影響 CVS Health 的主要新聞故事：</p>
</div><ul>
<li>Positive Sentiment: Morgan Stanley raised its price target on CVS Health and kept an overweight rating, signaling confidence in further upside after the company’s stronger-than-expected quarterly results. Morgan Stanley Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: Argus also lifted its outlook for CVS Health, adding to the wave of analyst support that may be helping shares move higher. Argus Issues Positive Forecast for CVS Health NYSE: CVS Stock Price</li>
<li>Positive Sentiment: CVS reported solid Q1 2026 earnings recently, beating estimates on both revenue and adjusted EPS, which continues to drive investor optimism about execution and valuation. Here is Why CVS Health (CVS) is One of the Cheap Stocks to Buy For the Next 10 Years</li>
<li>Positive Sentiment: CVS and WGU launched an online pre-pharmacy degree program to help build a stronger pharmacist pipeline, a move that could support long-term staffing and service growth. CVS Health® and WGU launch online pre-pharmacy degree program for future pharmacists nationwide</li>
<li>Neutral Sentiment: CVS advanced its portfolio reset by selling Omnicare after bankruptcy court approval, which simplifies the business and removes an underperforming unit, but also confirms ongoing restructuring. CVS Refocuses On Core Health Platform With Omnicare Sale And Drone Rollout</li>
<li>Neutral Sentiment: CVS also highlighted community and brand-building initiatives in Rhode Island, including its economic impact report and expanded WIC acceptance, which are positive for reputation but less likely to move the stock on their own. CVS Health’s Annual Impact in Rhode Island</li>
</ul>
<div class="lb-trans"><ul>
<li>積極情緒：摩根士丹利上調了對 CVS Health 的目標股價，並維持了增持評級，表明對公司超出預期的季度業績後進一步上漲的信心。摩根士丹利對 CVS Health 發佈積極預測 NYSE: CVS 股價</li>
<li>積極情緒：Argus 也提升了對 CVS Health 的展望，進一步增加了分析師支持的浪潮，這可能幫助股價上漲。Argus 對 CVS Health 發佈積極預測 NYSE: CVS 股價</li>
<li>積極情緒：CVS 最近公佈了 2026 年第一季度的強勁業績，收入和調整後每股收益均超出預期，這繼續推動投資者對執行和估值的樂觀情緒。以下是為什麼 CVS Health (CVS) 是未來 10 年值得購買的便宜股票</li>
<li>積極情緒：CVS 與 WGU 推出了一項在線藥學預科學位項目，以幫助建立更強大的藥劑師人才管道，這一舉措可能支持長期的人力資源和服務增長。CVS Health®與 WGU 推出全國未來藥劑師的在線藥學預科項目</li>
<li>中性情緒：CVS 通過在破產法庭批准後出售 Omnicare，推進了其投資組合重組，這簡化了業務並剔除了一個表現不佳的單位，但也確認了持續的重組。CVS 通過 Omnicare 出售和無人機推廣重新聚焦核心健康平台</li>
<li>中性情緒：CVS 還強調了在羅德島的社區和品牌建設舉措，包括其經濟影響報告和擴大 WIC 接受度，這對聲譽是積極的，但不太可能單獨推動股價。CVS Health 在羅德島的年度影響</li>
</ul>
</div><h2>About CVS Health</h2>
<div class="lb-trans"><h2>關於 CVS Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療解決方案。公司總部位於羅德島的伍恩索克特，追溯到 20 世紀 60 年代初，已發展成為一個綜合的處方藥、非處方產品、臨牀服務和健康保險提供商。其運營模式結合了零售藥房位置和店內診所，以及更廣泛的藥房和健康計劃能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 步入式醫療診所和提供擴展臨牀服務的 HealthHUB 地點。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Robinhood, SoFi, and Webull Are Telling Very Different Stories</li>
<li>As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In</li>
<li>Target the Red-Hot Spin-Off and Merger Space With These ETFs</li>
<li>Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 CVS Health</li>
<li>Robinhood、SoFi 和 Webull 講述截然不同的故事</li>
<li>當博通市值超過 2 萬億美元時，私人信貸巨頭想要參與</li>
<li>通過這些 ETF 瞄準火熱的分拆和合並領域</li>
<li>隨着 AI 內存需求激增，三星加入 1 萬億美元俱樂部</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CVS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 CVS 持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com，獲取 CVS Health Corporation (NYSE:CVS - 免費報告) 的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄推薦給客户的股票，以便在更廣泛的市場注意到之前購買……而 CVS Health 並不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

43,833 Shares in CVS Health Corporation $CVS Purchased by North Dakota State Investment Board

Market Beat

德意志銀行

高盛

美國銀行

Deutsche Bank AG Subscription Rights

Deutsche Postbank AG

GS Hldg R

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

北達科他州投資委員會購入了 CVS Health Corporation（股票代碼：$CVS）的 43,833 股股票